Bruker reported $813.2M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
ABB USD 7.3B 195M Mar/2026
Agilent USD 1.44B 9M Mar/2026
Ametek USD 10.92B 9.44B Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Fujikura JPY 280.92B 37B Mar/2026
Furukawa JPY 48.93B 1.64B Dec/2025
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Hitachi JPY 2.71T 314.71B Mar/2026
Illumina USD 852M 51M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Mitsubishi Electric JPY 1.35T 45.9B Dec/2025
Mitsubishi Heavy Industries JPY 1.51T 424.74B Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Nikon Corporation JPY 202.07B 67.73B Mar/2026
Olympus JPY 268.42B 35.37B Mar/2026
Repligen USD 174.27M 3.67M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Smiths GBP 749M 617M Jun/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 1.12B 457.15M Mar/2026